Quick Answer
Relay Therapeutics, Inc. reported Operating Income of -$302.74 million for fiscal year 2025.
Relay Therapeutics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$302.74M | +18.7% |
| 2024 | -$372.47M | +0.1% |
| 2023 | -$373.00M | -24.6% |
| 2022 | -$299.27M | +17.9% |
| 2021 | -$364.70M | -553.6% |
| 2020 | -$55.80M | +33.6% |
| 2019 | -$84.05M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$80.39M | +16.6% | -4.6% |
| June 30, 2025 | -$76.85M | +23.7% | +9.5% |
| March 31, 2025 | -$84.87M | +6.1% | +11.9% |
| September 30, 2024 | -$96.37M | -31.0% | +4.4% |
| June 30, 2024 | -$100.76M | +5.0% | -11.5% |
| March 31, 2024 | -$90.36M | +10.7% | -22.8% |
| September 30, 2023 | -$73.58M | +14.3% | +30.6% |
| June 30, 2023 | -$106.05M | -36.3% | -4.8% |
- Relay Therapeutics, Inc. showed an increase of +18.7% in Operating Income compared to the prior fiscal year.
- Over the 2019–2025 period, Relay Therapeutics, Inc.’s operating income has declined by 260.2% (from -$84.05 million to -$302.74 million).
- The most recent figure is from Relay Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: